ARCHIVES

Arzerra Promising For Heavily Pre-Treated CLL Patients

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

July 20, 2012

Southern Gets Two More Contracts Totaling 44.5 Million From NCI

June 14, 1974

Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says

March 21, 1997

Daily Humidification Improves Quality-of-Life in Phase III Trial

February 28, 2014

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010